Diagnostic and Evaluation of Hepato-pancreatico-biliary Disease With MRI

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-30

Study Completion Date

2023-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a retrospective review of images from patient data. There is no recruitment necessary for this study.

Research Question: Can advanced multiparametric MRI techniques improve the detection and characterization of focal and diffuse liver disease, accurately assess treatment response and predict patient outcomes based on longitudinal monitoring? Hypotheses: Advanced multiparametric MRI techniques improve the detection, characterization and response assessment of focal and diffuse liver disease and can predict serious liver related outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Non-invasive Diffusion-weighted Imaging With MRCP in the Diagnosis of Neoplastic Biliary Obstruction

NCT07108725

Non-invasive Diffusion-weighted Imaging Magnetic Resonance Cholangiopancreatography Diagnosis +1 more

RECRUITING

To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease

NCT07149571

Nonalcoholic Fatty Liver Disease Metabolic-associated Fatty Liver Disease

RECRUITING

Fully Automated High-Throughput Quantitative MRI of the Liver

NCT05294471

Healthy Iron Overload Liver Fat

RECRUITING

Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)

NCT01116804

Primary Liver Cancer

COMPLETED PHASE1

Magnetic Resonance Cholangio-pancreatography (MRCP) for Suspected Bilio-pancreatic Disease

NCT01538368

Suspected Bilio-pancreatic Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Diseases Pancreas Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Liver disease

Magnetic resonance imaging

Intervention Type DIAGNOSTIC_TEST

Advanced multiparametric MRI techniques to diagnose hepatic and pancreatic disease

Pancreatic disease

Magnetic resonance imaging

Intervention Type DIAGNOSTIC_TEST

Advanced multiparametric MRI techniques to diagnose hepatic and pancreatic disease

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Magnetic resonance imaging

Advanced multiparametric MRI techniques to diagnose hepatic and pancreatic disease

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with suspicion for or diagnosed focal and/or diffuse liver or pancreatic disease who underwent MRI of the abdomen.
* 18 years of age and older.